Workflow
OrthoPediatrics(KIDS)
icon
Search documents
OrthoPediatrics(KIDS) - 2020 Q2 - Earnings Call Transcript
2020-08-08 22:19
OrthoPediatrics Corp. (NASDAQ:KIDS) Q2 2020 Earnings Conference Call August 6, 2020 8:00 AM ET Company Participants Emma Poalillo - Investor Relations Mark Throdahl - Chief Executive Officer Fred Hite - Chief Operating Officer and Chief Financial Officer David Bailey - President Conference Call Participants Patrick Allen - Piper Sandler Ryan Zimmerman - BTIG Kaila Krum - Truist Securities Mike Matson - Needham and Company Dave Turkaly - JMP Securities Operator Welcome to the Q2 2020 OrthoPediatrics Corp Ear ...
OrthoPediatrics(KIDS) - 2020 Q2 - Quarterly Report
2020-08-06 17:43
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) As of August 4, 2020, the reg ...
OrthoPediatrics(KIDS) - 2020 Q1 - Earnings Call Transcript
2020-05-10 16:10
OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2020 Earnings Conference Call May 6, 2020 8:00 AM ET Company Participants Tram Bui - Investor Relations Mark Throdahl - President and Chief Executive Officer Fred Hite - Chief Financial Officer David Bailey - Executive Vice President Conference Call Participants Rick Wise - Stifel Matthew O’Brien - Piper Sandler Ryan Zimmerman - BTIG Kaila Krum - SunTrust Mike Matson - Needham & Company Dave Turkaly - JMP Securities Operator Ladies and gentlemen, thank you for standing ...
OrthoPediatrics(KIDS) - 2020 Q1 - Quarterly Report
2020-05-06 21:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (Mark One) | Title of Each Class | Trad ...
OrthoPediatrics(KIDS) - 2019 Q4 - Annual Report
2020-03-05 21:49
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K [Mark One] ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number 001-38242 ORTHOPEDIATRICS CORP. (Exact name of registrant as specified in its charter) Delaware 26-1761833 (State or other ...
OrthoPediatrics(KIDS) - 2019 Q4 - Earnings Call Transcript
2020-03-05 18:16
OrthoPediatrics Corp. (NASDAQ:KIDS) Q4 2019 Results Earnings Conference Call March 5, 2020 8:00 AM ET Company Participants Tram Bui - Investor Relations, The Ruth Group Mark Throdahl - President and Chief Executive Officer Fred Hite - Chief Financial Officer David Bailey - Executive Vice President Conference Call Participants Rick Wise - Stifel Nicolaus Drew Stafford - Piper Jaffray Ryan Zimmerman - BTIG David Saxon - Needham & Company Daniel Stauder - JMP Securities Kaila Krum - SunTrust Robinson Humphrey ...
OrthoPediatrics(KIDS) - 2019 Q3 - Quarterly Report
2019-11-08 19:22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (State or other jurisdic ...
OrthoPediatrics(KIDS) - 2019 Q3 - Earnings Call Transcript
2019-11-08 17:33
OrthoPediatrics Corp. (NASDAQ:KIDS) Q3 2019 Results Earnings Conference Call November 8, 2019 8:00 AM ET Company Participants Tram Bui - The Ruth Group Mark Throdahl - President, Chief Executive Officer Fred Hite - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Jaffray Ryan Zimmerman - BTIG Rick Wise - Stifel David Turkaly - JMP Securities Anna Nussbaum - William Blair Mike Matson - Needham & Company Operator Ladies and gentlemen, thank you for standing by and welcome to the Or ...
OrthoPediatrics(KIDS) - 2019 Q3 - Earnings Call Presentation
2019-11-08 13:04
OrthoPediatrics Corp. October 2019 Mark Throdahl, CEO David Bailey, EVP F Disclaimer Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of U.S. federal securities laws. You can identify forward-looking statements by the use of words such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "believe," "estimate," "project," "target," "predict," "intend," "future," "goals," "potential," "objective," "would" and other similar expressio ...
OrthoPediatrics (KIDS) Investor Presentation - Slideshow
2019-10-04 17:58
OrthoPediatrics Corp. October 2019 Mark Throdahl, CEO David Bailey, EVP F Disclaimer Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of U.S. federal securities laws. You can identify forward-looking statements by the use of words such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "believe," "estimate," "project," "target," "predict," "intend," "future," "goals," "potential," "objective," "would" and other similar expressio ...